Drug Trial Radar · NCT04307381
An Extension Study of Donidalorsen (IONIS-PKK-LRx) in Participants With Hereditary Angioedema
Last checked: Nov 20, 2026Latest source record: May 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
20
Actual
Start
Mar 31, 2020
Primary completion
Jan 24, 2025
Study completion Jan 24, 2025
Sponsor
- Lead sponsor
- Ionis Pharmaceuticals, Inc.Ionis Pharmaceuticals (IONS)
- Sponsor type
- Industry
- First posted
- Mar 13, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study was to evaluate the safety and efficacy of extended dosing of donidalorsen administered subcutaneously (SC), with alternative dosing and/or dose frequency with donidalorsen in participants with hereditary angioedema (HAE).
Conditions
- Hereditary Angioedema
Interventions
DonidalorsenDrug
Donidalorsen administered SC
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Treatment-emergent Adverse Events (TEAEs)Time frame: Up to Week 221
- Percentage of Participants With Clinically Meaningful Changes in Clinical Laboratory AssessmentsTime frame: Up to Week 221
- Percentage of Participants With Clinically Meaningful Changes in Vital SignsTime frame: Up to Week 221
- Percentage of Participants With Clinically Meaningful Changes in Electrocardiograms (ECGs) ParametersTime frame: Up to Week 221
- Percentage of Participants Who Received At Least One Concomitant MedicationTime frame: Up to Week 221
Locations
7 sites in 2 countries. Site status is shown where the registry gives one.
Ionis Investigative Site
Scottsdale, Arizona
Ionis Investigative Site
Santa Monica, California
Ionis Investigative Site
Plymouth, Minnesota
Ionis Investigative Site
Cincinnati, Ohio
Ionis Investigative Site
Hershey, Pennsylvania
Ionis Investigative Site
Dallas, Texas
Ionis Investigative Site
Amsterdam, Netherlands
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.